Melden Pharmaceuticals Private Limited
About Melden Pharmaceuticals Private Limited
Data last updated:
Melden Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74900KA2016PTC085576. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashwin Bhakat and Gangadhara Swetha.
Its last annual general meeting (AGM) was held on 06 November 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at No 67 5th Main 9th Cross R. C Agraha, Bangalore, Karnataka, India – 560018.
As per the financials filed for FY 2017, the company reported a revenue of ₹28.86 Lakh. For the same year it recorded a net profit of ₹82,864 (net margin 2.9%) and EBITDA of ₹1.38 Lakh (EBITDA margin 4.8%).
As per MCA filings, the company has open charges of ₹3 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo 67 5th Main 9th Cross R. C Agraha, Bangalore, Karnataka, India – 560018
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Melden Pharmaceuticals Private Limited
The main business activity of Melden Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Melden Pharmaceuticals Private Limited FY 2017 filings available
Melden Pharmaceuticals Private Limited reported revenue of ₹28.86 Lakh for FY 2017.
Financial Statement Summary of Melden Pharmaceuticals Private Limited
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹28.86 Lakh | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹1.38 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹82,864 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Melden Pharmaceuticals Private Limited
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.8% | •••• |
| Net Profit Margin | 2.9% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Melden Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Melden Pharmaceuticals Private Limited
Melden Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Paeon Pharmaceuticals Private Limited | ₹28.94 Lakh (FY 2019) | •••• | •••• | -6.0% | •••• | Lashkar, Madhya Pradesh, India |
| Routes Pharmaceuticals Private Limited | ₹28.93 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Bhopal, Madhya Pradesh, India |
| Arlon Pharmaceuticals Private Limited | ₹28.9 Lakh (FY 2024) | •••• | •••• | 161.0% | •••• | Pune, Maharashtra, India |
| Xemda Pharmaceuticals Private Limited | ₹28.89 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Uttam Nagar, New Delhi, Delhi, India |
| Unilead Pharmaceuticals Private Limited | ₹28.87 Lakh (FY 2024) | •••• | •••• | 77.0% | •••• | Kolkata, West Bengal, India |
| Melden Pharmaceuticals Private Limited this company | ₹28.86 Lakh (FY 2017) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| SBJ Pharmaceuticals Private Limited | ₹28.83 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Novotel Pharmaceuticals Private Limited | ₹28.82 Lakh (FY 2025) | •••• | •••• | 216.0% | •••• | Patna, Bihar, India |
| Novotra Pharmaceuticals Private Limited | ₹28.77 Lakh (FY 2023) | •••• | •••• | •••• | Baner, Maharashtra, India | |
| Baidyanath Horti.Agro and Plantations Private Limited | ₹28.75 Lakh (FY 2024) | •••• | •••• | -28.0% | •••• | Mumbai, Maharashtra, India |
| Sanatus Pharmaceuticals Private Limited | ₹28.71 Lakh (FY 2025) | •••• | •••• | •••• | Thiruvananthapuram, Kerala, India |
Peers are the five companies nearest above and the five nearest below Melden Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Melden Pharmaceuticals Private Limited
Melden Pharmaceuticals Private Limited is audited by K KALYANARAMAN & CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K KALYANARAMAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Melden Pharmaceuticals Private Limited
Melden Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwin Bhakat | Director | 28 Jan 2016 | 10 Years 8 Months | Current |
| Gangadhara Swetha | Director | 28 Jan 2016 | 10 Years 8 Months | Current |
| Gangadhar Shobha | Director | 27 Aug 2016 | 10 Years 1 Months | Current |
Ownership and Shareholding of Melden Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Melden Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2020 | Others | ₹3 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Melden Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Melden Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Melden Pharmaceuticals Private Limited
Melden Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Gangadhar Shobha was appointed as Director on 27 Aug 2016.
Credit Ratings, Litigation & Regulatory Alerts for Melden Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Melden Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Melden Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Melden Pharmaceuticals Private Limited
Melden Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Melden Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Melden Pharmaceuticals Private Limited
Melden Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 January 2016 (10+ years old) and is registered under CIN U74900KA2016PTC085576.
Melden Pharmaceuticals reported revenue of ₹28.86 Lakh for FY 2017.
Melden Pharmaceuticals has 3 current directors:
- Ashwin Bhakat - Director
- Gangadhara Swetha - Director
- Gangadhar Shobha - Director
Melden Pharmaceuticals reported a net profit of ₹82,864 (net margin 2.9%) and EBITDA of ₹1.38 Lakh (EBITDA margin 4.8%) for FY 2017, as per its filed financial statements.
No. Melden Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Melden Pharmaceuticals is U74900KA2016PTC085576. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Melden Pharmaceuticals was incorporated on 28 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Melden Pharmaceuticals by revenue are Paeon Pharmaceuticals Private Limited, Routes Pharmaceuticals Private Limited, Arlon Pharmaceuticals Private Limited, Xemda Pharmaceuticals Private Limited, Unilead Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Gangadhar Shobha was appointed as Director on 27 Aug 2016. Kesarala Krishnaiahshetty Vinay ceased to be Director on 26 Aug 2016. Ashwin Bhakat was appointed as Director on 28 Jan 2016. Melden Pharmaceuticals has 4 board changes on record in total.
The registered office of Melden Pharmaceuticals is at No 67 5th Main 9th Cross R. C Agraha, Bangalore, Karnataka, India – 560018.
Melden Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.